BIZALIMOGENE RALAPLASMID
UNII D8W2DVO5ZJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Bizalimogene Ralaplasmid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D8W2DVO5ZJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1977488-08-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D8W2DVO5ZJ

CAS Registry Number

1977488-08-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BIZALIMOGENE RALAPLASMID

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C77909

National Cancer Institute reference terminology for clinical and research data.

INN ID

10720

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-49

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bizalimogene Ralaplasmid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.